Gene Expression Differences Predict Treatment Outcome of Merkel Cell Carcinoma Patients
Due to the rarity of Merkel cell carcinoma (MCC), prospective clinical trials have not been practical. This study aimed to identify biomarkers with prognostic significance. While sixty-two patients were identified who were treated for MCC at our institution, only seventeen patients had adequate form...
        Saved in:
      
    
          | Main Authors: | Loren Masterson, Bryan J. Thibodeau, Laura E. Fortier, Timothy J. Geddes, Barbara L. Pruetz, Rajwant Malhotra, Richard Keidan, George D. Wilson | 
|---|---|
| Format: | Article | 
| Language: | English | 
| Published: | 
            Wiley
    
        2014-01-01
     | 
| Series: | Journal of Skin Cancer | 
| Online Access: | http://dx.doi.org/10.1155/2014/596459 | 
| Tags: | 
       Add Tag    
     
      No Tags, Be the first to tag this record!
   
 | 
Similar Items
- 
                
                    Updates in the Management of Merkel Cell Carcinoma        
                          
by: Paulo Henrique do Amor Divino, et al.
Published: (2019-01-01) - 
                
                    Case of Merkel cell carcinoma in a patient with pre-existing ILD        
                          
by: Richard Carvajal, et al.
Published: (2020-10-01) - 
                
                    Merkel Cell Carcinoma: The Past, the Present, and the Future        
                          
by: Inamaria Erovic, et al.
Published: (2013-01-01) - 
                
                    Vulvar Merkel Carcinoma: A Case Report        
                          
by: C. Iavazzo, et al.
Published: (2011-01-01) - 
                
                    Characterization of the Merkel Cell Carcinoma miRNome        
                          
by: Matthew S. Ning, et al.
Published: (2014-01-01)